Skip to main content

Bracebridge Capital, LLC

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1426486 BOSTON, MA

Position in AQST

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,910,338
+$4,592 QoQ
Shares Held
459,216
0.0% QoQ
Ownership
0.366%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#30
of 184 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AQST Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bracebridge Capital, LLC holds $16,812,908 across 2 Drug Manufacturers - Specialty & Generic names. AQST ranks #2 (11.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 AQST
Aquestive Therapeutics, Inc.
This page
459,216 $1,910,338

All Filings in AQST

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,910,338 459,216
2026-03-31 $1,905,746 459,216
2025-12-31 $2,966,535 459,216
2025-09-30 $2,567,017 459,216
2025-06-30 $1,520,004 459,216
2025-03-31 $1,331,726 459,216
2024-12-31 $1,634,808 459,216
2024-09-30 $2,134,283 428,571
2024-06-30 $1,114,284 428,571
2024-03-31 $1,825,712 428,571
2023-12-31 $865,713 428,571
2023-09-30 $655,713 428,571
2023-06-30 $707,142 428,571
2023-03-31 $488,570 428,571
2022-12-31 $386,571 428,571
2022-09-30 $501,428 428,571
2022-06-30 $274,285 428,571
2022-03-31 $1,118,570 428,571
2021-12-31 $1,667,141 428,571
2021-09-30 $1,868,569 428,571
2021-06-30 $1,701,426 428,571
2021-03-31 $2,228,569 428,571
2020-12-31 $2,292,854 428,571
2020-09-30 $2,080,712 428,571
2020-06-30 $2,082,855 428,571
2020-03-31 $938,570 428,571